Supreme Court Grants Cert in Amgen v. Sandoz & Sandoz v. Amgen
Patent – Patently-O 2017-01-19
Summary:
By Jason Rantanen Today, the Supreme Court granted certiorari in two dueling petitions involving the Federal Circuit’s 2015 interpretation of the Biologics Price Competition and Innovation Act of 2009. Here are the questions presented: Amgen v. Sandoz (1) Whether a biosimilar applicant is required by 42 U.S.C. § 262(l)(2)(A) to provide the reference product sponsor […]